CRYSTAL FORM OF HEPATITIS B SURFACE ANTIGEN INHIBITOR

The present invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method therefor, and also comprises the use of the crystal form in preparing the hepatitis B surface antigen inhibitor.

Saved in:
Bibliographic Details
Main Authors DING, Charles Z, SHI, Shenyi, HU, Yanbin, SUN, Fei, SU, Yanxiao
Format Patent
LanguageEnglish
French
German
Published 26.01.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method therefor, and also comprises the use of the crystal form in preparing the hepatitis B surface antigen inhibitor.
AbstractList The present invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method therefor, and also comprises the use of the crystal form in preparing the hepatitis B surface antigen inhibitor.
Author SHI, Shenyi
SUN, Fei
DING, Charles Z
HU, Yanbin
SU, Yanxiao
Author_xml – fullname: DING, Charles Z
– fullname: SHI, Shenyi
– fullname: HU, Yanbin
– fullname: SUN, Fei
– fullname: SU, Yanxiao
BookMark eNrjYmDJy89L5WQwdQ6KDA5x9FFw8w_yVfB3U_BwDXAM8QzxDFZwUggODXJzdHZVcPQL8XR39VPw9PPwdPIM8Q_iYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGFhamxiaWjibGRCgBAJW2KQc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate KRISTALLFORM DES HEPATITIS-B-OBERFLÄCHENANTIGEN-INHIBITORS
FORME CRISTALLINE D'UN INHIBITEUR D'ANTIGÈNE DE SURFACE DE L'HÉPATITE B
ExternalDocumentID EP3885349A4
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3885349A43
IEDL.DBID EVB
IngestDate Fri Oct 11 05:24:10 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3885349A43
Notes Application Number: EP20190887009
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220126&DB=EPODOC&CC=EP&NR=3885349A4
ParticipantIDs epo_espacenet_EP3885349A4
PublicationCentury 2000
PublicationDate 20220126
PublicationDateYYYYMMDD 2022-01-26
PublicationDate_xml – month: 01
  year: 2022
  text: 20220126
  day: 26
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Fujian Cosunter Pharmaceutical Co., Ltd
RelatedCompanies_xml – name: Fujian Cosunter Pharmaceutical Co., Ltd
Score 3.3757918
Snippet The present invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method therefor, and also comprises the use of the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CRYSTAL FORM OF HEPATITIS B SURFACE ANTIGEN INHIBITOR
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220126&DB=EPODOC&locale=&CC=EP&NR=3885349A4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL_MadQ3nRrnV_pgeCMqlAEPi-GjCMYBYZ2ZTwsFTPbCFofx3_dotumLvjVtcm0v-fV3d-1dAW5zPddMYQvVornWhm4KtbUSVJ1atBTmQyGkoziKB-GEPk-NaQfmm1wYWSf0SxZHREQViPdGntfLnyCWL99Wru7EHLsWjwEf-sraO9aQzrSB4rtDliZ-4imehy0lzoa6hbxEbYfuwC5a0WYLBvbqtkkpy9-MEhzBXorC6uYYOlXdgwNv8_FaD_ZH6_tubK6htzoBw8vextx5Iei2jUgSkJClDo94NCYuGU-ywPEYcWIePbGYRHEYuRFPslMgAeNeqOL8s-1eZyzdrlQ_g269qKtzIHaBwDMKszTudSoM23rPKz0X6MuUsmBcH_p_irn4Z-wSDlultSEFbXAF3ebjs7pGkm3EjVTPN4wKev0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH-Z0zhvOjXOzx4MN6JCGXBYDJQi1fER1pl5WijDZBe2OIz_voVs04vemjZ5bV_y6--9175XgNtMzzRT2EK1cKbVoZtcra0EVccWngnzIReNoxhG_WCMnyfGpAXzTS5MUyf0qymOKBGVS7xXzXm9_Aliec3bytWdmMuuxaPPB56y9o41SWdaX_HcAU1iLyYKIbKlROlAtyQvYdvBO7ArLWyzBgN9deuklOVvRvEPYS-RwsrqCFpF2YUO2Xy81oX9cH3fLZtr6K2OwSDp24g7QyTdthDFPgpo4nDG2Qi5aDROfYdQ5EScPdEIsShgLuNxegLIp5wEqpx_ut3rlCbbleqn0C4XZXEGyM4l8IzcnBn3OhaGbb1nhZ4J6cvMmoJxPej9Keb8n7Eb6AQ8HE6HLHq5gINagXV4QetfQrv6-CyuJOFW4rpR1Td78X3w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CRYSTAL+FORM+OF+HEPATITIS+B+SURFACE+ANTIGEN+INHIBITOR&rft.inventor=DING%2C+Charles+Z&rft.inventor=SHI%2C+Shenyi&rft.inventor=HU%2C+Yanbin&rft.inventor=SUN%2C+Fei&rft.inventor=SU%2C+Yanxiao&rft.date=2022-01-26&rft.externalDBID=A4&rft.externalDocID=EP3885349A4